These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7147923)

  • 1. [Changes in the active body-mass ratio (fatty mass) in hyperlipoproteinemias as affected by a combined dietetic regimen].
    Naumova R; Khandzhiev S
    Vutr Boles; 1982; 21(4):80-3. PubMed ID: 7147923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
    Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
    Kiriakov A; Malamov E; Apostolova Iu; Tsenov I; Tinterova Z
    Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperlipoproteinemias and proteinase inhibitor balance in patients with proliferative diabetic retinopathy with solid exudates in retina].
    Chesnokova NB; Kuznetsova TP; Davydova GA; Grigor'ev AV
    Vestn Oftalmol; 1999; 115(1):14-6. PubMed ID: 10207312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-segregation of elevated LDL with a novel mutation (D92K) of the LDL receptor in a kindred with multiple lipoprotein abnormalities.
    Wu LL; Hopkins PN; Xin Y; Stephenson SH; Williams RR; Nobe Y; Kajita M; Nakajima T; Emi M
    J Hum Genet; 2000; 45(3):154-8. PubMed ID: 10807540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
    Micheli H; Pometta D; Gustafson A
    Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary control of hyperlipoproteinemia.
    Lacatîs D; Bălan M; Creţeanu G
    Med Interne; 1980; 18(1):49-53. PubMed ID: 7375800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
    Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
    Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum lipid studies of hyperlipoproteinemia patients during diet therapy with pectin preparations].
    Apostolov I; Goranov I; Balabanski L; Krŭsteva A; Popova D
    Vutr Boles; 1982; 21(1):51-4. PubMed ID: 7090358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J; Martorell J
    Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estimation of the influence of psychological support on body mass reduction in the obese patients].
    Ostrowska L; Karczewski J
    Wiad Lek; 2002; 55(3-4):174-82. PubMed ID: 12182002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrocardiographic data on ischemic heart disease in hyperlipoproteinemia patients].
    Naumova R; Dimitrova G
    Vutr Boles; 1982; 21(4):57-61. PubMed ID: 7147920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia].
    Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN
    Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular complications in primary hyperlipoproteinemias (HLP) with special reference to changes in the eye fundus].
    Schulze J; Graupner K; Haller H; Hanefeld M; Leonhardt W
    Z Gesamte Inn Med; 1979 May; 34(10):121-2. PubMed ID: 483917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of a basic metabolic diet rich in polyene fatty acids on the pattern of glycerophospholipid fatty acids in patients with hyperlipoproteinemia].
    Reuter W; Heybey U
    Z Gesamte Inn Med; 1984 Mar; 39(6):100-2. PubMed ID: 6730581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition changes following laparoscopic gastric banding for morbid obesity.
    Strauss BJ; Marks SJ; Growcott JP; Stroud DB; Lo CS; Dixon JB; O'Brien PE
    Acta Diabetol; 2003 Oct; 40 Suppl 1():S266-9. PubMed ID: 14618490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of primary hyperlipoproteinemia during a preventive examination].
    Raslová K; Mongiellová V; Hucková M
    Cas Lek Cesk; 1993 Mar; 132(5):137-41. PubMed ID: 8472293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relation between lipoprotein fractions, sex and IHD in patients with primary hyperlipoproteinemia].
    Hora C; Hanefeld M; Leonhardt W; Jacob F; Haller H
    Z Gesamte Inn Med; 1982 Dec; 37(23):801-4. PubMed ID: 7164523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dietary effects of PUFA omega-3 on lipid peroxidation and antioxidant system in patients with IHD, hyperlipoproteinemia and hypertension].
    Pogozheva AV; Martynova EA; Samsonov MA; Egorova NI; Ksenofontova EA; Gorozhanskaia EG
    Vopr Pitan; 1994; (4):40-2. PubMed ID: 7817530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.